Ceftriaxone for Urinary Tract Infection
Ceftriaxone is not recommended as first-line therapy for uncomplicated UTI (cystitis) but is appropriate for complicated UTI and pyelonephritis at 1-2g IV/IM once daily for 7-14 days depending on severity. 1
Dosing and Duration by UTI Type
Uncomplicated Cystitis (Simple Bladder Infection)
- Ceftriaxone should NOT be used for uncomplicated cystitis - it represents overtreatment and should be reserved for more serious infections to minimize resistance development 1
- First-line agents are nitrofurantoin (5 days), TMP-SMX (3 days), or fluoroquinolones (3 days) when appropriate 2, 1
- β-lactams including ceftriaxone have insufficient evidence and lower efficacy compared to preferred agents for simple cystitis 2, 1
Acute Pyelonephritis (Kidney Infection)
- Dose: 1-2g IV or IM once daily for 7 days 2, 1, 3, 4
- For outpatient management: A single 1g IV/IM dose can be given initially, followed by oral fluoroquinolone to complete a 7-day course (if susceptible) 2, 1
- This approach allows transition to home therapy after initial parenteral dose 2
- Always obtain urine culture before initiating therapy 2, 1
Complicated UTI
- Dose: 1-2g IV once daily for 7-14 days 2, 1, 3, 4
- Duration of 7 days may be considered when the patient is hemodynamically stable and afebrile for at least 48 hours 2
- 14 days is recommended for men when prostatitis cannot be excluded 2
- For empirical treatment of complicated UTI with systemic symptoms, use an IV third-generation cephalosporin (such as ceftriaxone) 2
Administration Guidelines
Route and Timing
- Can be administered IV or IM 3, 4
- IV infusion should be given over 30 minutes in adults 3, 4
- In neonates, administer over 60 minutes to reduce risk of bilirubin encephalopathy 3, 4
- The usual adult daily dose is 1-2 grams given once daily depending on severity 3, 4
Important Safety Considerations
- Do NOT use diluents containing calcium (such as Ringer's solution or Hartmann's solution) as precipitate formation can occur 3, 4
- Ceftriaxone must not be administered simultaneously with calcium-containing IV solutions via Y-site 3, 4
- Contraindicated in neonates ≤28 days requiring calcium-containing IV solutions 3, 4
- No dosage adjustment necessary for renal or hepatic impairment 3, 4
Clinical Context and Efficacy
When to Use Ceftriaxone
- Hospitalized patients with complicated UTI requiring IV therapy 2
- Pyelonephritis in patients unable to tolerate oral therapy initially 2, 1
- When local fluoroquinolone resistance exceeds 10% 2
- Documented susceptibility to ceftriaxone on culture 1
Limitations
- β-lactams are less effective than fluoroquinolones or nitrofurantoin for UTIs in general 2, 1
- If oral β-lactam is used for pyelonephritis, an initial IV dose of long-acting parenteral antimicrobial (such as 1g ceftriaxone) is recommended 2
- Local resistance patterns should always guide empiric choices 2, 1
Transition to Oral Therapy
- After clinical improvement and when patient is afebrile for 48 hours, consider switching to oral therapy based on susceptibilities 2, 1
- In clinical trials, approximately 95% of patients were successfully switched from IV ceftriaxone to oral therapy after minimum 3 days 5
- Continue therapy for at least 2 days after signs and symptoms of infection have disappeared 3, 4
Common Pitfalls to Avoid
- Do not use ceftriaxone for simple cystitis - this is inappropriate overtreatment 1
- Always obtain urine culture before initiating therapy in complicated cases 2, 1
- Do not assume susceptibility - tailor therapy based on culture results 2, 1
- Avoid using ceftriaxone empirically if patient has used fluoroquinolones in last 6 months or is from urology department (higher resistance risk) 2